Literature DB >> 15890325

Nanotechnology in clinical laboratory diagnostics.

Kewal K Jain1.   

Abstract

Nanotechnology-the creation and utilization of materials, devices, and systems through the control of matter on the nanometer-has been applied to molecular diagnostics. This article reviews nanobiotechnologies that are clinically relevant and have the potential to be incorporated in clinical laboratory diagnosis. Nanotechnologies enable the diagnosis at single cell and molecule level and some of these can be incorporated in the current molecular diagnostics such as biochips. Nanoparticles, such as gold nanoparticles and quantum dots, are the most widely used but various other nanotechnologies for manipulation at nanoscale as well as nanobiosensors are reviewed. These technologies will extend the limits of current molecular diagnostics and enable point-of-care diagnosis as well as the development of personalized medicine. Although the potential diagnostic applications are unlimited, most important current applications are foreseen in the areas of biomarker research, cancer diagnosis and detection of infectious microorganisms.

Entities:  

Mesh:

Year:  2005        PMID: 15890325     DOI: 10.1016/j.cccn.2005.03.014

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  53 in total

1.  Zeta-potential Analyses using Micro Electrical Field Flow Fractionation with Fluorescent Nanoparticles.

Authors:  Moon-Hwan Chang; Dosi Dosev; Ian M Kennedy
Journal:  Sens Actuators B Chem       Date:  2007-06-10       Impact factor: 7.460

2.  Heterogeneous ligand-nanoparticle distributions: a major obstacle to scientific understanding and commercial translation.

Authors:  Douglas G Mullen; Mark M Banaszak Holl
Journal:  Acc Chem Res       Date:  2011-08-03       Impact factor: 22.384

3.  In vitro study investigating the mechanical properties of acrylic bone cement containing calcium carbonate nanoparticles.

Authors:  Janet Hill; John Orr; Nicholas Dunne
Journal:  J Mater Sci Mater Med       Date:  2008-05-24       Impact factor: 3.896

4.  A simulation study of the variability of indocyanine green kinetics and using structural a priori information in dynamic contrast enhanced diffuse optical tomography (DCE-DOT).

Authors:  Mehmet Burcin Unlu; Ozlem Birgul; Gultekin Gulsen
Journal:  Phys Med Biol       Date:  2008-05-27       Impact factor: 3.609

Review 5.  Emerging nanotechnology-based strategies for the identification of microbial pathogenesis.

Authors:  Charalambos Kaittanis; Santimukul Santra; J Manuel Perez
Journal:  Adv Drug Deliv Rev       Date:  2009-11-13       Impact factor: 15.470

6.  Multi-scale silica structures for improved HIV-1 Capsid (p24) antigen detection.

Authors:  Sophia Lin; Per Niklas Hedde; Vasan Venugopalan; Enrico Gratton; Michelle Khine
Journal:  Analyst       Date:  2016-06-20       Impact factor: 4.616

7.  [Gd@C(82)(OH)(22)](n) nanoparticles inhibit the migration and adhesion of glioblastoma cells.

Authors:  Jing Wang; Feng Gu; Ting Ding; Xiaoli Liu; Gengmei Xing; Yuliang Zhao; Ning Zhang; Yongjie Ma
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

Review 8.  Role and implications of nanodiagnostics in the changing trends of clinical diagnosis.

Authors:  Khalid Khalaf Alharbi; Yazeed A Al-Sheikh
Journal:  Saudi J Biol Sci       Date:  2013-11-19       Impact factor: 4.219

9.  Development of Thiolated-Graphene Quantum Dots for Regulation of ROS in macrophages.

Authors:  Byeongtaek Oh; Chi H Lee
Journal:  Pharm Res       Date:  2016-07-21       Impact factor: 4.200

10.  Label-free biomarker detection from whole blood.

Authors:  Eric Stern; Aleksandar Vacic; Nitin K Rajan; Jason M Criscione; Jason Park; Bojan R Ilic; David J Mooney; Mark A Reed; Tarek M Fahmy
Journal:  Nat Nanotechnol       Date:  2009-12-13       Impact factor: 39.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.